The Effect of Augmented Reality Based Telerehabilitation Application on Neuromuscular and Sensorimotor Parameters in Multiple Sclerosis Patients
Launched by ANKARA YILDIRIM BEYAZIT UNIVERSITY · Nov 26, 2022
Trial Information
Current as of February 05, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosed with relapsing remitting MS by a neurologist,
- • Having a disability level between 1 and 5 according to the Expanded Disability Status Scale (EDSS),
- • Those who get over 24 points in the Standardized Mini Mental State Test (SMMT),
- • Those who have not had an MS attack in the last three months,
- • Volunteer individuals
- Exclusion Criteria:
- • Receiving corticosteroid therapy in the last 4 weeks,
- • Having additional neurological disease that may cause balance disorder
- • Individuals who have had surgery related to the spine, hip, knee or ankle
About Ankara Yildirim Beyazıt University
Ankara Yıldırım Beyazıt University is a leading academic institution in Turkey, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its expertise in healthcare and innovative research methodologies to conduct ethical and scientifically rigorous clinical studies. By fostering collaboration among multidisciplinary teams, Ankara Yıldırım Beyazıt University aims to contribute to the development of novel therapies and enhance patient care, while adhering to the highest standards of regulatory compliance and patient safety.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
Similar Trials